671
Views
27
CrossRef citations to date
0
Altmetric
Drug Evaluations

Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials

, MD FRCPC, , , , , , , & show all
Pages 3061-3075 | Published online: 02 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Susan L McElroy, Anna Guerdjikova, Nicole Mori & Paul E Keck Jr. (2010) Therapeutic potential of new second generation antipsychotics for major depressive disorder. Expert Opinion on Investigational Drugs 19:12, pages 1527-1544.
Read now
Arun V Ravindran, Abdullah Al-Subaie & Gebrehiwot Abraham. (2010) Quetiapine: novel uses in the treatment of depressive and anxiety disorders. Expert Opinion on Investigational Drugs 19:10, pages 1187-1204.
Read now

Articles from other publishers (25)

Gerd Laux. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 11 .
Gerd Laux. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1859 1869 .
Johan Reutfors, Philip Brenner, Bob Brody, Heather Wray, Morten Andersen & Lena Brandt. (2019) A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case–Control Analyses of Select Outcomes. Drug Safety 43:2, pages 135-145.
Crossref
Yusuke Murata, Hiroko Matsuda, Yoko Mikami, Shiori Hirose, Masayoshi Mori, Kenji Ohe, Kazunori Mine & Munechika Enjoji. (2019) Chronic administration of quetiapine stimulates dorsal hippocampal proliferation and immature neurons of male rats, but does not reverse psychosocial stress-induced hyponeophagic behavior. Psychiatry Research 272, pages 411-418.
Crossref
Laura Orsolini, Federica Vellante, Alessandro Valchera, Michele Fornaro, Alessandro Carano, Maurizio Pompili, Giampaolo Perna, Gianluca Serafini, Marco Di Nicola, Giovanni Martinotti, Massimo Di Giannantonio & Domenico De Berardis. 2018. Understanding Depression. Understanding Depression 257 268 .
Konstantinos N. Fountoulakis, Lakshmi Yatham, Heinz Grunze, Eduard Vieta, Allan Young, Pierre Blier, Siegfried Kasper & Hans Jurgen Moeller. (2016) The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. International Journal of Neuropsychopharmacology, pages pyw100.
Crossref
Agnieszka Zagórska, Marcin Kołaczkowski, Adam Bucki, Agata Siwek, Grzegorz Kazek, Grzegorz Satała, Andrzej J. Bojarski, Anna Partyka, Anna Wesołowska & Maciej Pawłowski. (2015) Structure–activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity. European Journal of Medicinal Chemistry 97, pages 142-154.
Crossref
David J. Castle & Jens-Kristian Slott Jensen. (2015) Management of Depressive Symptoms in Schizophrenia. Clinical Schizophrenia & Related Psychoses 9:1, pages 13-20.
Crossref
Kostas N. FountoulakisKostas N. Fountoulakis. 2015. Bipolar Disorder. Bipolar Disorder 461 625 .
Irvin Epstein, Isaac Szpindel & Martin A. Katzman. (2014) Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies. Psychiatry Research 220, pages S15-S33.
Crossref
Anna Partyka, Jakub Jarosz, Anna Wasik, Magdalena Jastrzębska-Więsek, Agnieszka Zagórska, Maciej Pawłowski & Anna Wesołowska. (2014) Novel tricyclic[2,1- f ]theophylline derivatives of LCAP with activity in mouse models of affective disorders . Journal of Pharmacy and Pharmacology 66:12, pages 1755-1762.
Crossref
Bob Oranje & Birte Y. Glenthøj. (2014) Clonidine Normalizes Levels of P50 Gating in Patients With Schizophrenia on Stable Medication. Schizophrenia Bulletin 40:5, pages 1022-1029.
Crossref
Jeremy D. Coplan, Srinath Gopinath, Chadi G. Abdallah & Benjamin R. Berry. (2014) A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy. Frontiers in Behavioral Neuroscience 8.
Crossref
Caroline Nothdurfter, Christian Schmotz, Nina Sarubin, Thomas C. Baghai, Anna Laenger, Martin Lieb, Brigitta Bondy, Rainer Rupprecht & Cornelius Schüle. (2014) Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic–pituitary–adrenal-axis activity in relation to antidepressant effectiveness. Journal of Psychiatric Research 52, pages 15-20.
Crossref
Jimmi Nielsen, John M Kane & Christoph U Correll. (2012) Real‐world effectiveness of clozapine in patients with bipolar disorder: results from a 2‐year mirror‐image study. Bipolar Disorders 14:8, pages 863-869.
Crossref
Janusz K. Rybakowski, Kristof Vansteelandt, Tomasz Szafranski, Eric Thys, Marek Jarema, W. Wolfgang Fleischhacker, René S. Kahn & Joseph Peuskens. (2012) Treatment of depression in first episode of schizophrenia: Results from EUFEST. European Neuropsychopharmacology 22:12, pages 875-882.
Crossref
David Castle & Peter Bosanac. (2018) Depression and schizophrenia. Advances in Psychiatric Treatment 18:4, pages 280-288.
Crossref
Jung‐Goo Lee, Jong‐Il Lee, Yang‐Tae Kim, Chul‐Eung Kim, Chang‐Yoon Kim, Jin‐Sang Yoon, So‐Young Yoo & Young‐Hoon Kim. (2012) Safety of quetiapine fumarate extended release in the treatment of Korean patients with acute schizophrenia. Human Psychopharmacology: Clinical and Experimental 27:4, pages 403-410.
Crossref
Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller & Eduard Vieta. (2012) Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience 262:S1, pages 1-48.
Crossref
Roger S McIntyre & Jinju Yoon. (2012) Efficacy of antimanic treatments in mixed states. Bipolar Disorders 14, pages 22-36.
Crossref
Cecilio Álamo & Francisco López-Muñoz. (2012) Eficacia de quetiapina de liberación prolongada en la sintomatología afectiva. Revista de Psiquiatría y Salud Mental 5, pages 3-19.
Crossref
Ian M. Anderson. 2013. Behavioral Neurobiology of Depression and Its Treatment. Behavioral Neurobiology of Depression and Its Treatment 263 289 .
Francisco E. Estevez-Carrizo, Susana Parrillo, Mónica Cedres Ercoli & Francisco T. Estevez-Parrillo. (2011) Single-Dose Relative Bioavailability of a New Quetiapine Fumarate Extended-Release Formulation: A Postprandial, Randomized, Open-Label, Two-Period Crossover Study in Healthy Uruguayan Volunteers. Clinical Therapeutics 33:6, pages 738-745.
Crossref
Paul E. KeckJrJr, Susan L. McElroy & John M. Hawkins. (2011) Bipolar Disorder. Psychopharm Review 46:4, pages 25-30.
Crossref
. (2011) Current World Literature. Current Opinion in Psychiatry 24:1, pages 78-87.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.